Nivolumab vs Rivaroxaban
Nivolumab vs Rivaroxaban: Overview
This comparison examines the pharmacological differences between Nivolumab and Rivaroxaban.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Rivaroxaban: Direct Factor Xa inhibitor.
Pharmacokinetics
Half-life: Nivolumab β 27 days; Rivaroxaban β 5-9 hours.
Chemical Properties
Molecular Formula: Rivaroxaban β C19H18ClN3O5S.
Molecular Weight: Rivaroxaban β 435.8820 g/mol.
Type: Nivolumab β Antibody; Rivaroxaban β Small molecule.